Serum adiponectin and resistin levels in major depressive disorder

Acta Psychiatrica Scandinavica

Volumn 121, Issue 3, 2010, Pages 209-215

  Lehto, S M ^a,b   Huotari, A ^c   Niskanen, L ^a   Tolmunen, T ^a   Koivumaa Honkanen, H ^d   Honkalampi, K ^b   Ruotsalainen, H ^c   Herzig, K H ^a,c   Viinamaki H ^a   Hintikka, J ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Kuopio Psychiatric Center   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Adiponectin; Coronary heart disease; Major depressive disorder; Metabolic syndrome, resistin

Indexed keywords

ADIPONECTIN; BIOCHEMICAL MARKER; BIOLOGICAL MARKER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEASUREMENT; METABOLIC SYNDROME X; OBESITY; POPULATION RESEARCH; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMICS; STATISTICAL ANALYSIS; SYMPTOM; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; CORONARY DISEASE; DEMOGRAPHY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OVERWEIGHT; RESISTIN; SEVERITY OF ILLNESS INDEX; SOCIOECONOMIC FACTORS;

EID: 76449103646     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2009.01463.x     Document Type: Article

References (52)

1. Maes M, Bosmans E, Suy E, Vandervorst C, Dejonckheere C, Raus J. Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1 beta and soluble interleukin-2 receptor production. Acta Psychiatr Scand 1991 84 : 379 386.
2. Maes M, Bosmans E, Meltzer HY. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. Eur Arch Psychiatry Clin Neurosci 1995 245 : 172 178.
3. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 2009 65 : 732 741.
4. Suarez EC, Lewis JG, Krishnan RR, Young KH. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004 29 : 1119 1128.
5. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006 27 : 24 31.
6. Eller T, Vasar V, Shlik J, Maron E. Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 445 450.
7. Leo R, Di Lorenzo G, Tesauro M et al. Decreased plasma adiponectin concentration in major depression. Neurosci Lett 2006 407 : 211 213.
8. Yudkin JS, Juhan-Vague I, Hawe E et al. Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. Metabolism 2004 53 : 852 857.
9. Han SH, Quon MJ, Kim JA, Koh KK. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007 49 : 531 538.
10. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006 6 : 772 783.
11. Steppan CM, Bailey ST, Bhat S et al. The hormone resistin links obesity to diabetes. Nature 2001 409 : 307 312.
12. Hivert MF, Sullivan LM, Fox CS et al. Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. J Clin Endocrinol Metab 2008 93 : 3165 3172.
13. Sheng CH, Di J, Jin Y et al. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008 33 : 135 143.
14. Heidemann C, Sun Q, Van Dam RM et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008 149 : 307 316.
15. Brunetti L, Orlando G, Recinella L, Michelotto B, Ferrante C, Vacca M. Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus. Eur J Pharmacol 2004 493 : 41 44.
16. Narita K, Murata T, Takahashi T, Kosaka H, Omata N, Wada Y. Plasma levels of adiponectin and tumor necrosis factor-alpha in patients with remitted major depression receiving long-term maintenance antidepressant therapy. Prog Neuropsychopharmacol Biol Psychiatry 2006 30 : 1159 1162.
17. Pan A, Ye X, Franco OH et al. The association of depressive symptoms with inflammatory factors and adipokines in middle-aged and older Chinese. PLoS ONE 2008 3 : e1392.
18. Berg AH, Schrerer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005 96 : 939 949.
19. Frasure-Smith N, Lespérance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry 2008 65 : 62 71.
20. Kowalska I, Straczkowski M, Nikolajuk A et al. Insulin resistance, serum adiponectin, and proinflammatory markers in young subjects with the metabolic syndrome. Metabolism 2008 57 : 1539 1544.
21. Vanhala M, Jokelainen J, Keinänen-Kiukaanniemi S, Kumpusalo E, Koponen H. Depressive symptoms predispose females to metabolic syndrome: a 7-year follow-up study. Acta Psychiatr Scand 2009 119 : 137 142.
22. Li M, Fisette A, Zhao XY, Deng JY, Mi J, Cianflone K. Serum resistin correlates with central obesity but weakly with insulin resistance in Chinese children and adolescents. Int J Obes (Lond) 2009 33 : 424 439.
23. Viinamäki H, Heiskanen T, Lehto SM et al. Depressive symptoms are associated with metabolic syndrome in men. Acta Psychiatr Scand 2009 120 : 23 29.
24. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961 4 : 561 571.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). Washington, DC : American Psychiatric Association, 1994.
26. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960 23 : 56 62.
27. Williams JBW, Terman M. Structured interview guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS). New York : New York State Psychiatric Institute, 2003.
28. Elshal MF, Mccoy JP. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 2006 38 : 317 323.
29. De Jager W, Te Velthuis H, Prakken BJ, Kuis W, Rijkers GT. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 2003 10 : 133 139.
30. Leng SX, Mcelhaney JE, Walston JD, Xie D, Fedarko NS, Kuchel GA. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J Gerontol A Biol Sci Med Sci 2008 63 : 879 884.
31. Pischon T, Hotamisligil GS, Rimm EB. Adiponectin: stability in plasma over 36 hours and within-person variation over 1 year. Clin Chem 2003 49 : 650 652.
32. Expert Panel on detection, evaluation and treatment of high blood cholesterols in adults. Executive summary of the third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001 285 : 2486 2497.
33. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome. An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005 112 : 2735 2752.
34. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004 66 : 411 421.
35. Weber-Hamann B, Kratzsch J, Kopf D et al. Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment. J Psychiatr Res 2007 41 : 344 350.
36. Räikkönen K, Matthews KA, Kuller LH. The relationship between psychological risk attributes and the metabolic syndrome in healthy women: antecedent or consequence? Metabolism 2002 51 : 1573 1577.
37. Heiskanen TH, Niskanen LK, Hintikka JJ et al. Metabolic syndrome and depression: a cross-sectional analysis. J Clin Psychiatry 2006 67 : 1422 1427.
38. Takahashi N, Anan F, Nakagawa M et al. Hypoadiponectinemia in type 2 diabetes mellitus in men is associated with sympathetic overactivity as evaluated by cardiac 123I-metaiodobenzylguanidine scintigraphy. Metabolism 2007 56 : 919 924.
39. Tanida M, Shen J, Horii Y et al. Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats. Exp Biol Med 2007 232 : 390 397. (Pubitemid 46334055)
40. Mössner R, Mikova O, Koutsilieri E et al. Consensus paper of the WFSBP Task Force on Biological Markers: biological markers in depression. World J Biol Psychiatry 2007 8 : 141 174.
41. Stewart JW, Mcgrath PJ, Quitkin FM, Klein DF. Atypical depression: current status and relevance to melancholia. Acta Psychiatr Scand 2007 115 (suppl. 433 58 71.
42. Lehto SM, Tolmunen T, Joensuu M et al. Changes in midbrain serotonin transporter availability in atypically depressed subjects after one year of psychotherapy. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 229 237.
43. Fink M, Taylor MA. The medical evidence-based model for psychiatric syndromes: return to a classical paradigm. Acta Psychiatr Scand 2008 117 : 81 84.
44. Hung YJ, Hsieh CH, Chen YJ et al. Insulin sensitivity, proinflammatory markers and adiponectin in young males with different subtypes of depressive disorder. Clin Endocrinol (Oxf) 2007 67 : 784 789.
45. Narita K, Murata T, Hamada T et al. Adiponectin multimer distribution, not absolute amount of plasma, correlates with depression severity in healthy elderly subjects. Prog Neuropsychopharmacol Biol Psychiatry 2008 32 : 124 127.
46. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003 88 : 5452 5455.
47. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 2002 290 : 1084 1089.
48. Halleux CM, Takahashi M, Delporte ML et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 2001 288 : 1102 1107.
49. National Agency for Medicines and Social Insurance Institute. Finnish statistics on medicines 2006. National Agency for Medicines and Social Insurance Institute, Helsinki, 2007.
50. Findlay JWA, Smith WC, Lee JW et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal 2000 21 : 1249 1273.
51. Pajvani UB, Hawkins M, Combs TP et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem 2004 279 : 12152 12162.
52. Hara K, Horikoshi M, Yamauchi T et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care 2006 29 : 1357 1362.